scholarly article | Q13442814 |
P50 | author | Michael J Iadarola | Q67499869 |
Peter D Burbelo | Q90463908 | ||
P2093 | author name string | Marinos C Dalakas | |
Sandra Groot | |||
P2860 | cites work | A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins | Q24813048 |
Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I | Q28142020 | ||
The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid | Q31406782 | ||
The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome | Q34512042 | ||
Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase | Q34566310 | ||
Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. | Q36363509 | ||
Technology insight: can autoantibody profiling improve clinical practice? | Q36735396 | ||
Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome | Q41196484 | ||
GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes | Q41507641 | ||
Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase | Q41562794 | ||
Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases | Q42206137 | ||
Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems). | Q43034262 | ||
Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies | Q43734068 | ||
Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. | Q44757080 | ||
Markedly elevated GAD antibodies in SPS: effects of age and illness duration | Q45185832 | ||
Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity | Q47311183 | ||
Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome | Q47671744 | ||
A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies | Q49290849 | ||
Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. | Q51582170 | ||
An autoantibody to GAD65 in sera of patients with juvenile neuronal ceroid lipofuscinoses. | Q52111422 | ||
Advantages and pitfalls of radioimmune and enzyme linked immunosorbent assays of insulin antibodies. | Q52869745 | ||
The quest for brain disorder biomarkers | Q56894858 | ||
Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients | Q71606041 | ||
Engineered variants of human glutamic acid decarboxylase (GAD) and autoantibody epitope recognition | Q73676795 | ||
Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus | Q77734820 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autoantibody | Q785022 |
P304 | page(s) | 1-7 | |
P577 | publication date | 2007-11-29 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome | |
P478 | volume | 366 |
Q36842064 | A new luminescence assay for autoantibodies to mammalian cell-prepared insulinoma-associated protein 2. |
Q48300084 | A novel LIPS assay for insulin autoantibodies. |
Q36967203 | Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). |
Q35876586 | Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia |
Q35182392 | Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. |
Q35187324 | Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS) |
Q39236510 | Anticonvulsant effects by bilateral and unilateral transplantation of GABA-producing cells into the subthalamic nucleus in an acute seizure model |
Q28264405 | Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes |
Q36731462 | Benefits and risks of intranigral transplantation of GABA-producing cells subsequent to the establishment of kindling-induced seizures |
Q34200288 | Calpain cleavage of brain glutamic acid decarboxylase 65 is pathological and impairs GABA neurotransmission |
Q38063547 | Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation |
Q37190897 | Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection |
Q95840283 | GAD antibodies in neurological disorders - insights and challenges |
Q37358994 | GAD65 autoimmunity-clinical studies. |
Q39689062 | Glutamatergic excitation and GABA release from a transplantable cell line |
Q33814536 | High levels of Anti-GAD65 and Anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbance |
Q37196366 | Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies |
Q38156224 | Immunology of stiff person syndrome and other GAD-associated neurological disorders |
Q35013894 | Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases |
Q36045361 | No Evidence of Antibodies against GAD65 and Other Specific Antigens in Children with Autism |
Q36853493 | Novel detection of pancreatic and duodenal homeobox 1 autoantibodies (PAA) in human sera using luciferase immunoprecipitation systems (LIPS) assay |
Q34267557 | Rapid induction of autoantibodies during ARDS and septic shock |
Q37384083 | Rapid serological detection of autoantibodies associated with Sjögren's syndrome |
Q24646797 | Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection |
Q37281501 | Searching for biomarkers: humoral response profiling with luciferase immunoprecipitation systems |
Q36160086 | Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome |
Q37116538 | Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay |
Q28295552 | The immunological basis for treatment of stiff person syndrome |
Q35112489 | Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis. |
Search more.